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Argonaute are a conserved class of proteins central to the microRNA pathway. We have highlighted a
novel and non-redundant function of Ago1 versus Ago2; the two core factors of the miRNA-associ-
ated RISC complex. Stable overexpression of Ago1 in neuroblastoma cells causes the cell cycle to
slow down, a decrease in cellular motility and a stronger apoptotic response upon UV irradiation.
These effects, together with a signiﬁcant increase in p53 levels, suggest that Ago1 may act as a
tumor-suppressor factor, a function also supported by GEO Proﬁles microarrays that inversely cor-
relate Ago1 expression levels with cell proliferation rates.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction sufﬁcient to induce its repression [2], demonstrating the centralityArgonaute (Ago) proteins belong to a conserved gene family
found in plants, yeast, Drosophila and mammals. The mammalian
protein family consists of the Ago and Piwi subfamilies, each
represented by four members [1]. Ago proteins are ubiquitously
expressed and their structure consists of a less conserved amino-
terminal domain and three highly conserved domains: the Mid do-
main and the signature PAZ and Piwi domains. Despite their high
sequence similarity, the endonuclease activity is unique of Ago2.
In mammals, the best-studied members of this family are Ago1
and Ago2 as they represent the major component of RISC, the micr-
oRNA (miRNA) effector complex.
miRNAs are genome encoded small RNA molecules deriving
from processing of longer double stranded precursors, which con-
trol gene expression post-transcriptionally. miRNAs interact with
Ago proteins and guide the RISC complex on bound mRNA targets,
leading to their degradation or translational repression. Artiﬁcial
tethering of Ago proteins to the 30UTR of a reporter mRNA ischemical Societies. Published by E
Cellular Biotechnology and
sity, 00161 Rome, Italy. Fax:
otto).of these factors in miRNA mediated regulation.
By regulating the post-transcriptional expression of a large
number of genes, miRNAs control a wide range of physiological
processes, including proliferation, differentiation, cell metabolism
and migration. Indeed, their deregulation has been associated with
several human diseases, including neurodegenerative processes
and cancer [3,4]. In particular, miRNAs can function as oncogenes
or tumor suppressors by targeting genes which are key regulators
of tumor progression and tumorigenesis is often accompanied by a
general downregulation of miRNAs [3]. Additionally, both up- and
down-regulation of proteins involved in miRNA biogenesis, such as
Drosha and Dicer, are associated with cancer progression [5,6].
Being so central to miRNA function, misregulation of Ago proteins
should likely affect cell proliferation and differentiation. However,
little is known about either direct or miRNA-mediated effects of
these proteins on the cell cycle. Further, PAR-CLIP experiments
and proﬁles of Ago1 and Ago2-associated miRNAs seem to indicate
that Ago proteins bind the same miRNAs and mRNA targets, sug-
gesting a functional redundancy of these two factors [7,8].
To challenge this view and investigate potential non-redundant
roles of mammalian Ago1 and Ago2, we overexpressed both pro-
teins in a neuroblastoma cell line. We observed that Ago1 has a
clear inhibitory effect on cell proliferation and motility whilelsevier B.V. All rights reserved.
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sor factors.
2. Materials and methods
Quantitative data are represented as the mean ± SD. The Stu-
dent’s t-test was used for statistical analysis (⁄P < 0.05 and
⁄⁄P < 0.001).
DNA constructs, primer sequences, buffers, cell culture proto-
cols, antibodies and sources are described in Supplemental Data.
2.1. Stable cell lines generation
SH-SY5Y cells were transfected with pCMV-Flag-Ago1, pCMV-
Flag-Ago2 or pCMV-Flag-empty vector using Lipofectamine 2000.
Cells were diluted to clonal density 24 h post-transfection, and se-
lected based on their resistance toG418 (300 lMfor 10 days). Single
cloneswere picked and independently grownunder selection, to ob-
tain monoclonal cell lines; the remaining clones from each plate
were expanded to generate polyclones. Monoclones and polyclones
were further selected based on their Flag-Ago expression.
2.2. Induction of neuronal differentiation
Eighty percentage conﬂuent SH-SY5Y cells were exposed to 1%
FBS and 10 lM Retinoic Acid for ﬁve days. At 0, 1, 2, 3 and 5 days
of treatment, images of the differentiating cells were taken with
Nikon ECLIPSE TE2000-E inverted microscope with 10–20  lenses.
Neurite outgrowth was measured using NIS software. At least 100
neurites were measured for each sample.
2.3. Western blot analysis and RT-PCR
Cells were lysed with lysis buffer, spun 10 min at 10000g, and
samples were subjected to western blot analysis. Semi-quantita-
tive RT-PCR was performed using One-step SuperscriptIII RT-PCR
following manufacturer protocols with oligos Ago1f, Ago1r, Ago2f,
and Ago2r.
2.4. Trypan blue exclusion and FACS analyses
2  104 cells were seeded in 48-well plates and trypsinized, try-
pan blue stained and counted at 24, 48 and 72 h. In FACS analyses,
7.5  105 cells were plated in 10 cm dishes, trypsinized 24 h later
and ﬁxed at a concentration of 1  106 cells/ml. 500.000 cells were
PBS washed and resuspended in RNaseA (75 KU/ml) and propidium
iodide (50 lg/ml) overnight. Samples were measured with a FAC-
Scan cytoﬂuorimeter and 20,000 events/samples were acquired
using CELLQuest BD software. Cell cycle phases percentages were
estimated using ModFit software.
2.5. Wound healing and motion analyses
A conﬂuent plate of cells was wounded with a tip to induce the
edge of the monolayer of cells to heal the empty space. Cells buf-
fered with 15 mM HEPES (pH 7.2) at 37 C and a time-lapse movie
was taken acquiring images every 5 min for 18 h. A Zeiss Axiovert-
35 microscope equipped with a JVC digital CCD camera (50 objec-
tive) and the IAS2000 software (Deltasistemi) was used. The speed
of migration was calculated dividing the average distances covered
by individual nuclei by the time of observation.
2.6. Cell invasion assay
In vitro cell invasion assays were performed using Matrigel-
coated inserts according to manufacturer protocols, with2.5  105 cells/insert and10% FBS as chemoattractant. After 24 h,
migrated cells were ethanol ﬁxed and stained with 0.1% crystal vio-
let in 20% methanol. Images of ﬁve different ﬁelds (10 objective)
for each ﬁlter were taken and cells were counted. The mean of four
experiments done in duplicate was evaluated for each clone.
2.7. UV irradiation
Eighty percentage conﬂuent cells were exposed to UV irradia-
tion (8 mJ/cm2) 1 h post-medium replacement, and incubated for
24 h. After ﬁxing with 4% PFA, apoptotic and non-apoptotic nuclei
were Hoechst-stained and counted. In each experiment apoptotic
nuclei were counted in 10 different areas (40  objective) of each
coverslip and normalized against the total number of cells in the
ﬁeld.
3. Results
3.1. Ago1 overexpressing cells show a proliferation defect
We generated stable SH-SY5Y neuroblastoma cell lines
overexpressing Ago1 and Ago2 proteins to test whether they par-
ticipate in modulating cell cycle and differentiation pathways.
SH-SY5Y cells were chosen because both proteins are normally ex-
pressed in this cell type [9,10].
We choose to overexpress rather than downregulate these fac-
tors, to avoid compensatory effects of related members of this
highly conserved family of proteins. To this aim, we have stably
transfected SH-SY5Y cells with plasmids expressing either FLAG-
Ago1, FLAG-Ago2 or a control empty vector. Three independent
monoclones and a polyclone were selected for each Ago protein
based on their expression levels detected by western blot assays
and semi-quantitative RT-PCR (Fig. 1).
We initially tested potential differences between the prolifera-
tion rates of our clones by comparing their growth curves over a
72 h period. As shown in Fig. 2A, Ago1 overexpression results in
a signiﬁcant reduction of the monoclones’ proliferation rate
(mAgo1). In particular, already 48 h after plating we registered a
50% reduction of mAgo1’s growth rate compared to both control
and Ago2 monoclones (mAgo2). Similarly, Ago1-overexpressing
polyclone (PolAgo1) shows a comparable proliferative defect with
respect to both control and Ago2 polyclone (PolAgo2) (Fig. 2B).
We next asked whether the different proliferation rates of our
clones correlated with a different cell cycle distribution. Propidium
iodide and FACS analyses of both monoclones and polyclones re-
vealed that Ago1 overexpression causes a 20% increase in G1/G0
cells concomitantly with a 15% decrease of cells in S phase
(Fig. 3). Ago2, on the other hand, does not seem to affect cell cycle
distribution when overexpressed.
Moreover, lack of sub-G1 peaks in the FACS analysis, indicate
that Ago1 overexpression does not induce cell death of SH-SY5Y
(data not shown).
These results indicate that Ago1 overexpression slows down
SH-SY5Y cell cycle, likely as a consequence of a delay in G1/S tran-
sition, while upregulation of Ago2 does not exert any effect.
3.2. Both Ago1 and Ago2 overexpression induce SH-SY5Y
differentiation
SH-SY5Y cells can be induced to differentiate into neuronal-like
cells upon ﬁve days of all-trans retinoic acid (RA) treatment [11].
Thus, we examined whether Ago1 and Ago2 overexpression can in-
duce differentiation per se or have an effect on RA-induced differ-
entiation. Neurite length and expression of neuronal protein
markers, such as gap-43 and bIII-tubulin, were chosen as parame-
ters of the differentiation status. Even before RA treatment, neurite
AB
C
Fig. 1. Overexpression of Ago1 and Ago2 proteins in SH-SY5Y. Western Blot
analyses with anti-Flag antibody, showing the expression of Flag-Ago1 (A) and Flag-
Ago2 (B) in three monoclones (mAgo) and in a polyclone (PolAgo) normalized
against b-actin. Ctr: cells transfected with empty plasmid. (C) Semi-quantitative RT-
PCR of Ago1 and Ago2 mRNAs using total RNA from Ctr, PolAgo1, PolAgo2 and from
two representative monoclones (mAgo1c and mAgo2c).
A
B
Fig. 2. Cell growth analysis. (A) Cell growth curves of mAgo1, mAgo2 and Ctr clones
determined by trypan blue assays. Three experiments were done in triplicate on
three different mAgo1, mAgo2 and Ctr monoclones. (B) The same analysis was
performed on PolAgo1, PolAgo2.
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compared to control cells (Fig. 4A, B). Additionally, during the ﬁrst
three days of RA induction, PolAgo1 and PolAgo2 clones maintain a
similar increment of neurite length with respect to control. How-
ever, after longer exposures to RA, all clones reach the same differ-
entiation status with comparable neurite outgrowth (Fig. 4B, T5
time point). Consistently, the neuronal marker bIII-tubulin is sig-
niﬁcantly more expressed in PolAgo1 and PolAgo2 clones at day
3 of RA induction than in control clones, while at day 5 all clones
show similar expression levels of this protein. Interestingly, Gap-
43 is up-regulated by the overexpression of Ago proteins both
before and after RA treatment (Fig. 4C), in line with the differenti-
ation phenotype of PolAgo1 and PolAgo2. Both Ago1 and Ago2
monoclones behaved similarly to polycones in our differentiation
analyses (data not shown), conﬁrming the eliciting effect of Ago1
and Ago2 overexpression on SH-SY5Y neuronal differentiation.
3.3. Ago1 overexpression results in a less invasive phenotype of SH-
SY5Y
The growth and differentiation phenotypes observed upon Ago1
overexpression are reminiscent of those induced by a tumor sup-
pressor factor. Given that a characteristic feature of cancer cells is
their ability to invade surrounding tissues, we next investigated
whetherAgo1andAgo2canaffect neuroblastomacells invasiveness.
In awoundhealing assay, themigration rate of all polycloneswas re-
corded and reported as themean value registered for at least 20 cells
for each clone in three independent experiments. In Fig. 5A, repre-
sentative photographs show the healing process at 0 and 18 h after
wounding, a time point chosen because shorter than SH-SY5Y dou-
bling time.Weobserved that PolAgo1 cells cover an area20% smal-
ler than the one healed by control and PolAgo2 cells. Additionally,
the average rate of migration of Ago1 cells (150.32 ± 2.27 lm/h) is
at least 25% lower than control (200.48 ± 9.72 lm/h) and Ago2 cells
(232.55 ± 5.43 lm/h) (Fig. 5B). These data suggest that Ago1overex-
pression, in addition to modulating growth rate and differentiation,
also leads to a decrease in the motility of cells.
To further test the metastatic potential of our clones, we per-
formed an invasion assay, in which cells are induced to migrate
through matrigel-coated ﬁlters. As shown in Fig. 6, Ago1 overex-
pression reduces the invasiveness of SH-SY5Y cells by about 50%
compared to both control and PolAgo2 cells. Overall these analyses
indicate that Ago1 overexpressing cells are characterized by a re-
duced metastatic potential, in agreement with the tumor suppres-
sor phenotype suggested above.
3.4. Ago1 overexpression results in the accumulation of p53
To gain insight into the molecular mechanisms that mediate the
phenotypic effects of Ago1 overexpression in SH-SY5Y cells, we
analysed the expression levels of key regulatory proteins involved
in cell cycle and proliferation. Overexpression of Ago1 leads to a
signiﬁcant increase in p53 protein levels, which are unchanged in
Ago2 overexpressing cells (Fig. 7). Semi-quantitative RT-PCR anal-
yses show that p53 mRNA levels are unaffected by the overexpres-
sion of either Ago protein (data not shown), indicating that p53
protein enrichment in PolAgo1 is not due to an increase in tran-
scription or stability of its mRNA, but rather to an increase in sta-
bility or translation efﬁciency of the protein.
A widely used method to assess p53 activation involves an
evaluation of the response to genotoxic stimuli, such as UV irradia-
tion. Apoptotic nuclei were counted by Hoechst staining 24 h after
UV-exposure and, consistently with increased p53 levels, Ago1-
overexpressing cells showed an augmented sensitivity to UV-
irradiation, more than doubling the number of apoptotic nuclei
per ﬁeld (Fig. 8A). Conversely, Ago2 overexpressing cells were not
AB
Fig. 3. Cell cycle analysis. Cell cycle phases distribution of mAgo1, mAgo2, PolAgo1, PolAgo2 and Ctr clones obtained by propidium iodide cell staining and FACS analysis as
reported in Section 2. For each clone a representative DNA histogram (A) and the mean percentage of the cell population in each cell cycle phase (B) are shown. n = 4 For
monoclones and n = 2 for polyclones.
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supported by an increase of cleaved Caspase-3 levels in PolAgo1 ex-
tracts, a characteristic featureof cells undergoing apoptosis (Fig. 8B).
4. Discussion
We have stably overexpressed Ago1 and Ago2 proteins in a SH-
SY5Yneuroblastoma cell line to identify novel and speciﬁc functions
of these two orthologs. Both Ago1- and Ago2-overexpressing clones
displaymore prominent neurite outgrowth than their control coun-
terparts, even before activation of the differentiation pathway with
retinoic acid, suggesting that theover-expressionof either protein in
sufﬁcient per se to induce neural differentiation. Interestingly, it has
been previously shown that differentiation by RA does not depend
on an increase of endogenous Ago proteins as their abundance is
unaffected by RA treatment of a neuroblastoma cell line [9].Biochemically, our result is paralleled by the expression pattern of
the differentiation marker Gap43, up-regulated in both PolAgo1
and PolAgo2 even before RA induction. The phenotypic and bio-
chemical effects exerted by the overexpression of these factors is
however lost at late time points (5 days) after RA treatment. Wes-
ternblots ofbIII-tubulin reveal a similarproﬁle; its levels areup-reg-
ulated in the context of Ago1 or Ago2 overexpression at 3 days of RA
treatment but merge with control levels at 5 days. These data sug-
gest an overlapping function, likely miRNA-mediated, of Ago1 and
Ago2 in neuronal differentiation. Redundancy of Ago1 and Ago2
function in miRNA-regulated pathways is indicated by proﬁles of
the miRNAs associated with each Ago protein and recent PAR-CLIP
experiments [8], showing that these two factors bind the same pool
of miRNAs and mRNA targets.
However, when analyzing the proliferation proﬁles of our
clones, we observed a non-redundant effect of Ago1 versus Ago2;
AB C
Fig. 4. Differentiation analysis. (A) Representative images of cells before (day 0) and after 3 and 5 days of RA induction. (B) The mean length at least 100 neurites is shown for
each clone at the indicated time points. Scale bar: 100 lm. (C) Representative western blot of bIII-tubulin and Gap-43 expression in Ctr, PolAgo1 and PolAgo2 clones before
and after RA induction.
A
B
Fig. 5. Motility assay. (A) Representative images of Ctr, PolAgo1 and PolAgo2 clones
at time 0 and 18 h after wounding. (B) Histogram depicting average speed of the
different clones from three independent experiments.
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due to a delay in the G1/S transition. Additionally, high levels of
Ago1 decrease cellular motility, in wound healing and invasion as-
says, and induce a stronger apoptotic response upon UV exposure.
Thus, Ago1 overexpression rescues four hallmark features of tumor
cells, suggesting that Ago1 behaves as a tumor suppressor factor
when up-regulated. Parallel analyses of Ago2 overexpressing
clones reveal no signiﬁcant effect in any of the phenotypical fea-
tures tested, differently from what was observed in human breast
cancer cells. In these cells, high levels of Ago2 correlated with an
enhanced proliferation and migration ability [12].
This unexpected effect of Ago1 is supported by data from the
public functional genomics data repository GEO Proﬁles [13]. Sev-
eral microarray analyses of differentiating and tumorigenic cells
reveal an inverse correlation between Ago1 expression levels and
cellular division rates. In several tumor cell lines Ago1 levels are
signiﬁcantly lower, while Ago2 is unperturbed (GEO Accession:
GDS1375/218287 and GDS1375/ 213310 [14]). Accordingly, region
1p34–35 of chromosome 1, which includes Ago1 gene, is often de-
leted in Wilms’ tumors and has been associated with neuro-
ectodermal tumours [10,15]. Ago1’s potential role in modulating
the cell cycle is also corroborated by its expression proﬁles in
microarray analyses of differentiating neurons during brain
embryogenesis; being very low when mostly undifferentiated
neural progenitors are present, but growing signiﬁcantly when
they begin to differentiate into neurons (GEO Accession:
GDS3442/1434331 and GDS3442/1426366 [16]). Additionally, it
AB
Fig. 6. Cell invasion assay. (A) Representative images of cells migrated though matrigel or control inserts. (B) ‘‘Invasion index’’ is plotted for each clone, representing the
number of matrigel-invading cells normalized against control insert-migrating cells. n = 5.
Fig. 7. p53 expression levels. Western blot of PolAgo1, PolAgo2, Ctr, mAgo1(c) and
mAgo2(c) lysates with p53 and b-actin antibodies, representative of four indepen-
dent experiments.
A B
Fig. 8. Apoptosis induction. (A) Histogram representing the percentage of apoptotic
nuclei upon UV-irradiation. n = 6. (B) Western blot analysis for Caspase-3 on clones
lysed 24 h after UV irradiation. The antibody recognizes both full length (35 kDa)
and cleaved (17 kDa) Caspase 3.
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again its abundance with cell cycle arrest. These data, together
with our results, suggest that Ago1 likely plays a role in down-
regulating cell proliferation in multiple cellular contexts, raising
several complex questions regarding Ago proteins functional
redundancy and mode of action. It has been reported that the
length of G1 may be a primary modulator of neuronal differentia-
tion [17], thus in principle Ago1 over-expression may induce dif-
ferentiation as a mere consequence of its effects on the cell cycle.
However, it should be noted that Ago2 over-expression has a sim-
ilar inﬂuence on neuronal differentiation without noticeably
affecting cell cycle progression. This suggests that, at least in this
case, the effects observed on cell differentiation are uncoupled
from those observed on cell proliferation.
Two alternative scenarios can be imagined in interpreting our
data: Ago1 effects on the cell cycle could be caused by misregula-
tion of miRNAs or could be due to a miRNA-independent process
that involves Ago1.
In the miRNA dependent scenario, Ago1 unique effects could be
only explained by a non-redundant function of Ago1 versus Ago2.
A possible solution in this direction is offered by differential roles
played by Ago proteins in miRNA biogenesis [18,19]. In particular,
Ago1 was identiﬁed as part of a large multiprotein complex com-
mitted to miRNA maturation from pre-miRNA in a neuronal cell
line. Moreover, the non-redundant phenotype of Ago proteins
overexpression may be due to Ago2’s unique endonucleolytic
activity, which may inﬂuence both the loading of miRNAs on RISC
complexes and the degradation of speciﬁc target mRNAs.
It may otherwise be that these effects depend on accessory fac-
tors speciﬁcally associated with Ago1. One such example is
TRIM32, a protein that induces neuronal differentiation by binding
Ago1 and increasing the activity of speciﬁc miRNAs [20].
In the alternative scenario, the tumor suppressor-like effects
observed only upon Ago1 overexpression, and not in Ago2 clones,
C. Parisi et al. / FEBS Letters 585 (2011) 2965–2971 2971could be explained by functions of Ago1 that are independent of
miRNAs.
Studies in S. Pombe, have shown that Ago1 is required for a nor-
mal G1/S transition, cytokinesis and the response to DNA damage
[21]. Interestingly, miRNAs are not expressed in S. Pombe and
Ago1 associates with factors directly involved in regulating the cell
cycle [22].
miRNA-independent functions of Ago1 protein are also sup-
ported by Ago1 mutants isolated in Arabidopsis, either defective
in RNAi but functional in development or viceversa, indicating that
control of these two processes by Ago1 can be uncoupled [23].
It should be noted that the effects of Ago1 on the cell cycle at
the G1/S transition are in accordance with both the miRNA-
dependent and independent scenarios. Indeed, most cell cycle-
targeting miRNAs modulate this speciﬁc checkpoint [24]. Likewise,
Ago1 mutants are defective in G1 arrest in S. Pombe, where miR-
NAs are absent [21].
An indication of the molecular mechanism underlying the phe-
notypic alterations of Ago1 overexpressing cells comes from the
evidence that p53 levels are strongly upregulated in these clones.
A connection between Ago1 and p53 levels is in accordance
with recent studies linking p53 to the miRNA pathway; p53 is a
miRNA target, a transcriptional regulator of miRNAs and is in-
volved in miRNA biogenesis [25,26]. However, a pathway in which
p53 is part of the tumor suppressor cascade activated by Ago1 is
compatible with both miRNA-dependent and independent
scenarios.
In conclusion, our data provide insights that further the under-
standing of the Argonaute family of proteins, suggesting a novel
role for Ago1 in downregulating cell proliferation and motility. Fu-
ture work should unravel the molecular cascade that underlies the
effects of Ago1 overexpression and test potential applications in
cancer treatments.
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